We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

febit First to Offer Newly Published Mouse Genome on a Chip for DNA/RNA Detection and Enrichment

febit technology is claimed to enable the conversion of new sequence data into biochips for Next-Generation Sequencing within days.
News

Delay in Diagnosis of Menopause-Like Condition in Young Women Linked to Low Bone Density

A delay in diagnosing the condition may make women more susceptible to osteoporosis and fractures later in life, NIH researchers say.
News

Drug Discovery Unit, University of Dundee, and DNDi Collaborate to Identify Drug Candidates to Treat Visceral Leishmaniasis

The £1.8m collaboration focuses on the discovery and development of affordable and effective therapies for the disease.
News

Engineering Innovative Solutions for 21st Century Medicine

EPSRC announced £41M funding for four new UK Centres of Excellence in Medical Engineering.
News

Evotec Strengthens its Ion Channel Capabilities to Support new Alliances

Addition of ion channel focused library and additional electrophysiology equipment to support ion channel screening and medicinal chemistry alliances.
News

FDA's Current Ability to Regulate Genetic Testing is Problematic, FDLI-AAAS Colloquium Attendees Say

Personalized medicine stakeholders’ meeting elicits varying perspectives.
News

Gene Expression Findings a Step toward Better Classification and Treatment of Juvenile Arthritis

Findings could enable clinicians to target more aggressive treatment to children at risk of more severe arthritis.
News

Increased Demand Drives Queensland Compound Library Expansion

QCL capacity is increased by the acquisition of an additional comPOUND® storage module.
News

Leti Startup to Provide Improved Cancer Surgery

Fluoptics’ optical imaging system enhances detection and helps surgery.
News

MorphoSys Reports Filing for Phase 1b/2a Trial for its Lead Program MOR103 in Rheumatoid Arthritis

The trial to be conducted in multiple centers in several European countries, is expected to enroll 135 patients in total beginning in the second half of 2009.
Advertisement